Impact of Antimicrobial Stewardship on Antimicrobial Utilization and Resistance Patterns in a Tertiary Care Hospital in Western Maharashtra.

BACKGROUND

Non-judicious use of antibiotics by health professionals has been identified as an area for interventions and improvement by the World Health Organization for controlling antimicrobial resistance. Following the Indian Council for Medical Research (ICMR) guidelines, we established an antimicrobial stewardship (AMS) program at the 950-bedded multispecialty private sector hospital located in western Maharashtra by the end of the year 2021.

AIM AND

OBJECTIVE

The purpose of this study was to evaluate the impact of an AMS program intervention on the utilization of antibiotics and resistance patterns of organisms isolated from the patients.

RESULT: A significant reduction in the utilization of ceftriaxone (23.3 to 6.75), piperacillin-tazobactam (7.7 to 6.0), amikacin (9.03 to 5.15), clindamycin (6.25 to 5.75), linezolid (5.8 to 4.8), and ceftazidime (0.9 to 0.2) in defined daily doses (DDD/100 bed days) was seen after intervention. Antibiotic resistance decreased in gentamicin, amikacin, and teicoplanin. Overall antibiotic consumption reduced from 1,681.0 to 1,420.0 DDD/100 days. Culture-based therapy increased from 61% to 90%. Surgical prophylaxis compliance increased from 58% to 96%.

CONCLUSION

The constant perseverance of the AMS team of our hospital had a positive impact on reducing the overall consumption of antibiotics. Stringent infection prevention and control practices, timely provision of treatment guidelines, frequent interactions and discussions with treating doctors, audits by clinical pharmacists, and feedback to the doctors along with various training programs and sensitization sessions by the AMS team have brought significant behavioral changes among the treating physicians.